The Lawson lab is interested in understanding the cellular and molecular mechanisms underlying the metastatic spread of cancer cells to peripheral tissues. They take a systems-level approach, using cutting edge single-cell technologies to study intratumor heterogeneity in human patient-derived xenograft (PDX) models and identify pre-metastatic cells within primary tumors. Their work is aimed at defining the key genetic and transcriptomic programs that confer special fitness for metastasis in rare cancer cells, and understand how the interplay between intracellular signals within those cancer cells, and extracellular stimuli from the microenvironment (e.g. immune cells) influence the metastatic potential of individual cancer cells. The overarching goals are to identify new therapeutic strategies to prevent progression to lethal metastatic disease in cancer patients.
112 Sprague Hall
140 Sprague Hall